[u'-----BEGIN PRIVACY-ENHANCED MESSAGE-----\nProc-Type: 2001,MIC-CLEAR\nOriginator-Name: webmaster@www.sec.gov\nOriginator-Key-Asymmetric:\n MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen\n TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB\nMIC-Info: RSA-MD5,RSA,\n SaHvZLWCwz5TH+jajDqRzviREINC9qPC8gL92rpHCfxOUXD8N3Fq11r+c+nhG3Sg\n +ms6XxldMcELa0AhokrScw==\n\n', u'0000801748-04-000013.txt : 20040930\n', u'0000801748-04-000013.hdr.sgml : 20040930\n', u'20040930120555\nACCESSION NUMBER:\t\t0000801748-04-000013\nCONFORMED SUBMISSION TYPE:\t8-K\nPUBLIC DOCUMENT COUNT:\t\t1\nCONFORMED PERIOD OF REPORT:\t20040930\nITEM INFORMATION:\t\tResults of Operations and Financial Condition\nFILED AS OF DATE:\t\t20040930\nDATE AS OF CHANGE:\t\t20040930\n\nFILER:\n\n\tCOMPANY DATA:\t\n\t\tCOMPANY CONFORMED NAME:\t\t\tHEMACARE CORP /CA/\n\t\tCENTRAL INDEX KEY:\t\t\t0000801748\n\t\tSTANDARD INDUSTRIAL CLASSIFICATION:\tSERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]\n\t\tIRS NUMBER:\t\t\t\t953280412\n\t\tSTATE OF INCORPORATION:\t\t\tCA\n\t\tFISCAL YEAR END:\t\t\t1231\n\n\tFILING VALUES:\n\t\tFORM TYPE:\t\t8-K\n\t\tSEC ACT:\t\t1934 Act\n\t\tSEC FILE NUMBER:\t000-15223\n\t\tFILM NUMBER:\t\t041054582\n\n\tBUSINESS ADDRESS:\t\n\t\tSTREET 1:\t\t21101 OXNARD STREET\n\t\tCITY:\t\t\tWOODLAND HILLS\n\t\tSTATE:\t\t\tCA\n\t\tZIP:\t\t\t91367\n\t\tBUSINESS PHONE:\t\t818-226-1968\n\n\tMAIL ADDRESS:\t\n\t\tSTREET 1:\t\t21101 OXNARD STREEET\n\t\tCITY:\t\t\tWOODLAND HILLS\n\t\tSTATE:\t\t\tCA\n\t\tZIP:\t\t\t91367\n', u'\n', u'\n', u'8-K\n', u'1\n', u'rel8k2qr.txt\n', u'CORRECTION TO PRESS RELEASE DATED AUGUST 13, 2004\n', u"\n                     UNITED STATES\n           SECURITIES AND EXCHANGE COMMISSION\n                Washington, D.C. 20549\n\n\n                       FORM 8-K\n\n\n                    CURRENT REPORT\n           Pursuant to Section 13 OR 15(d) of\n         The Securities Exchange Act of 1934\n\n\nDate of Report (Date of earliest event reported): September 29, 2004\n\n\n                 HemaCare Corporation\n(Exact name of registrant as specified in its charter)\n\n\n  California              000-15223  \t\t  95-3280412\n(State or other          (Commission            (IRS Employer\njurisdiction\t\t File Number)         Identification No.)\nof incorporation)\n\n                      21101 Oxnard Street\n                      Woodland Hills, CA   \t      91367\n           (Address of principal executive offices) (Zip Code)\n\nRegistrant's telephone number, including area code:  818-226-1968\n\n\n\nCheck the appropriate box below if the Form 8-K filing is\nintended to simultaneously satisfy the filing obligations of the\nregistrant under any of the following provisions:\n\n[ ] Written communications pursuant to Rule-425 under the\n    Securities Act (17 CFR 230.425)\n[ ] Soliciting material pursuant to Rule 14a-12 under the\n    Exchange Act (17 CFR 240.14a-12)\n[ ] Pre-commencement communications pursuant to Rule 14d-2(b)\n    under the Exchange Act (17 CFR 240.14d-2(b))\n[ ] Pre-commencement communications pursuant to Rule 13e-4(c)\n    under the Exchange Act (17 CFR 240.13e-4(c))\n\n", u'\n\n\nItem 2.02  Results of Operations and Financial Condition\n\nOn August 13, 2004, HemaCare Corporation issued a press release\n(the "Release") announcing financial results for the three\nmonth and six month periods ended June 30, 2004.  A copy was\nattached as Exhibit 99.1 to the Company\'s report on Form 8-K\nfiled with the SEC on August 13, 2004.\n\nAttached to the Release was a table of condensed consolidated\nfinancial data.  This table inadvertently indicated that (i) the\ngross profit for the three month period ended June 30, 2003 was\n$6,485,000 instead of the correct amount of $452,000, (ii) the\ngross profit for the six month period ended June 30, 2004 was\n$10,723,000 instead of the correct amount of $2,934,000, and\n(iii) that the gross profit for the six month period ended June\n30, 2003 was $12,416,000 instead of the correct amount of\n$1,452,000.  All of the other numbers presented in the table of\ncondensed consolidated financial data were correct as originally\npublished and are unaffected by this correction.  The information\ncorrected in this Current Report on Form 8-K was accurately\nreported in the Company\'s report on Form 10-Q filed with the SEC\non August 13, 2004.\n\nThe information in this Current Report on Form 8-K, including the\nexhibits, will not be treated as "filed" for the purposes of\nSection 18 of the Securities and Exchange Act of 1934 (the\n"Exchange Act") or otherwise subject to the liabilities of\nthat section.  This information will not be incorporated by\nreference into a filing under the Securities Act of 1933, or into\nanother filing under the Exchange Act, unless that filing\nexpressly refers to specific information in this report.\n\n                        SIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of\n1934, the registrant has duly caused this report to be signed on\nits behalf by the undersigned hereunto duly authorized.\n\n\n\t\t\t\t     HEMACARE CORPORATION\n\t                                (Registrant)\n\nDate: September 30, 2004\t   By:  /s/ Robert S. Chilton\n                                   _______________________________\n\t\t\t           Robert S. Chilton,\n\t                           Chief Financial Officer\n\n\n\n\n', u'\n', u'\n', u'\n-----END PRIVACY-ENHANCED MESSAGE-----\n']